Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Paxlovid is the most commonly prescribed at home treatment for COVID-19 in the U.S. It is approved to treat COVID in adults who are at risk of severe complications from the illness.

Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19. In December 2021, the FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric ...

Dr. Astha Muttreja, a physician at the Stony Brook Medicine's post-COVID Clinic in Lake Grove, said there had been “cautious optimism” that Paxlovid would be a potential treatment method for ...

Paxlovid made no significant improvement to long COVID symptoms, including fatigue, brain fog and body aches. The finding “does not rule out” Paxlovid as a therapy, the researchers wrote.

The findings are described in a paper to be published June 7 in JAMA Internal Medicine. Paxlovid is a highly effective antiviral agent licensed for treatment of acute COVID-19.

FDA researchers estimated, based on Covid rates in January, that Paxlovid could "lead to 1,500 lives saved and 13,000 hospitalizations averted each week" in the U.S.

Paxlovid isn't the only antiviral medication for COVID-19. Merck’s Lagevrio is another available pill, though it's proven to be less popular in the U.S. than Paxlovid.

Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.

As soon as doctors determined on Thursday that President Biden had Covid-19, the White House doctor put him on the antiviral Paxlovid. Considered a game-changer when it was authorized in December ...